U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Monoclonal antibodies reactive with defined regions of the T-cell antigen receptor

Patent 5223426 Issued on June 29, 1993. Estimated Expiration Date: Icon_subject June 29, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Monoclonal antibodies that recognize human T cells
Patent #: 4550086
Issued on: 10/29/1985
Inventor: Reinherz ,   et al.

Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays
Patent #: 4845026
Issued on: 07/04/1989
Inventor: Kung ,   et al.

Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof
Patent #: 4886743
Issued on: 12/12/1989
Inventor: Hood, et al.

T cell specific cDNA clone Patent #: 4923799
Issued on: 05/08/1990
Inventor: Mak

Inventors

Assignee

Application

No. 449692 filed on 12/11/1989

US Classes:

435/331, Immunoglobulin or antibody binds a specifically identified amino acid sequence424/144.1, Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., NK cell, etc.)424/154.1, T lymphocytic cell (e.g., T cell, thymocyte, etc.)530/387.1, Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed530/387.9, Binds specifically-identified amino acid sequence530/388.22, Binds receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.)530/388.75Binds T-lymphocytic cell or component or product thereof (e.g., T cell, thymocyte, T-lineage bone marrow cell, T-lymphoblastoid cell, T-lineage acute lymphoblastic leukemia cell, T-lymphocytic cell-surface antigen, etc.)

Examiners

Primary: Nucker, Christine M.
Assistant: Sidberry, Hazel F.

Attorney, Agent or Firm

Foreign Patent References

  • 0180171A2 EP. 10/13/1985
  • 0180878A2 EP. 10/13/1985
  • 0200350A2 EP. 03/13/1986
  • 0289252A2 EP. 11/13/1988
  • 0340109A2 EP. 04/13/1989
  • 0250333A1 DE. 10/13/1987
  • 61-254529 JP. 11/13/1986
  • 63-030500 JP. 02/13/1988
  • 2197323A GB. 05/13/1988
  • WO84/02848 WO. 08/13/1984
  • WO88/00209 WO. 01/13/1988
  • WO89/02899 WO. 04/13/1989
  • WO89/05309 WO. 06/13/1989

International Classes

A61K 039/00
A61K 035/16

Abstract

The present invention relates to monoclonal antibodies which recognize defined regions of the T-cell receptor (TCR). In a specific embodiment, the invention provides monoclonal antibodies which are reactive with a constant region of the alpha chain of the TCR. In particular embodiments, the invention relates to two monoclonal antibodies, termed 򳇱 and 򳇲, which react with two different epitopes on the framework region of the ଱ monomer of the TCR molecule. In another specific embodiment, the invention is directed to monoclonal antibodies reactive with a variable region of the beta chain of the TCR. In particular, the invention provides two monoclonal antibodies, termed W112 and 2D1, which react with ଲ chain variable regions V댥.3 and V댨.1, respectively. In another specific embodiment, the invention is directed to monoclonal antibodies reactive with a variable region of the delta chain of the TCR. In particular, the invention provides monoclonal antibody δTCS1, isotype IgG2a. The monoclonal antibodies of the invention have value in diagnosis and therapy and are useful tools for study of the immune system.

Other References

  • Sim et al, Nature vol. 312 pp. 771-775 1984
  • Saito et al, Nature vol. 309 Jun. 1984, pp. 757-762
  • Minami et al, The Journal of Biol Chem vol. 262 Sep. 1987, pp. 13342-13347
  • Fabbi et al., Eur J Imn. 15 1985 pp. 821-827
  • Brenner et al, The J of Im. vol. 138 1502-1509 Mar. 1, 1987
  • Acuto et al, Cell vol. 34, pp. 717-726 1983
  • Kappler Cell vol. 35 1983 pp. 295-302
  • Maecker and Levy (1989), J. Immunol. 142:1395-1404
  • Posnett et al. (1986), Proc. Nat'l Acad. Sci. USA 83: 7888-7892
  • Boylston et al. (1986), J. Immunol. 137: 741-744
  • Bigler and Chiorazzi, (1987) in the Molecular Basis of B-Cell Differentiation and Function, Ferrerini and Pernis, eds., Plenum Press, pp. 123-130
  • Bigler et al. (1985), J. Exp. Med. 161: 1450-1463
  • Bigler et al. (1983), J. Exp. Med. 158: 1000-1005
  • Spits et al. (1985), J. Immunol. 135: 1922-1928
  • Samelson et al. (1983), Proc. Nat'l Acad. Sci. U.S.A. 80: 6972-6976
  • Reinherz et al. (1984), Immunol. Rev. 81: 95-129
  • Meuer et al. (1983), J. Exp. Med. 157: 705-719
  • McIntyre and Allison (1983), Cell 34: 739-746
  • Marchalonis (1987), Antigen-Specific T-Cell Receptors and Factors, vols. I and II, Marchalonis (Ed.), CRC Press, Boca Raton, Fla., Table of Contents and pp. 18-21
  • Brenner et al. (1984), J. Exp. Med. 160:541-551
  • Tian et al. (1989) FASEB J., 3: A486 (and poster)
  • Borst et al. (1987), J. Immunol. 139: 1952-1959
  • Brenner et al. (1987), J. Immunol. 138: 1502-1509
  • Maecker et al. (1987), J. Immunol. Methods 98: 219-226
  • Picker et al. (1987), Am. J. Pathol. 129: 434-440
  • Ng et al. (1988), Am. J. Pathol. 132: 365-371
  • Moller et al. (1988), J. Clin. Invest. 82: 1183-1191
  • Tillinghast et al. (1986), Science 233: 879- 883
  • Waldmann et al. (1985), New Eng. J. Med. 313: 776-783
  • Schluter et al. (1986), Proc. Nat'l Acad. Sci. U.S.A. 83: 1872-187
  • Kappler et al. (1989), Science 244: 811-813
  • Brennan et al. (1988), J. Autoimmum. 1: 319-326
  • Grossi et al. (1989), Proc. Nat'l Acad. Sci. U.S.A. 86: 1619-1623
  • Wu et al. (1988), J. Immunol. 141: 1476-1479
  • Augustin et al. (1989), Nature 340: 239-241
  • Ferrini et al. (1987), J. Exp. Med. 166: 277-282
  • Brenner et al. (1986) Nature 322: 145-149
  • Compana et al. (1989), J. Immunol. 142: 57-66
  • Janson et al. (1989a), Cancer Immunol. Immunother. 28: 225-232
  • Janson et al. (1989b), in Human Tumor Antigens and Specific Tumor Therapy, Alan R. Liss, Inc. pp. 277-286
  • Wraith et al. (1989), Cell 57: 709-715
  • Howell et al. (1989), Science 246:668-670
  • Ashwell et al. (1987), Science 237: 61-64
  • Urban et al. (1988), Cell 54: 577-592
  • Acha-Orbea et al. (1988), Cell 54: 263-273
  • Vacchio and Hodes (1989), J. Exp. Med. 170: 1335-1346
  • Webb and Sprent (1987), J. Exp. Med. 165: 584-589
  • Janson et al. (1987), Scand. J. Immunol. 26: 237-246
  • Behlke et al. (1987), J. Exp. Med. 165: 257-262
  • Fowlkes et al. (1987) Nature 329: 251-254
  • Payne et al. (1988) Proc. Nat'l Acad. Sci. U.S.A. 85: 7695-7698
  • Staerz et al. (1985), J. Immunol. 134: 3994-4000
  • Haskins et al. (1984), J. Exp. Med. 160: 452-471
  • Chan and Takei (1986), J. Immunol. 136: 1346-1355
  • Guy et al. (1989), Science 244: 1477-1480
  • Traunecker et al, Eur. J. Immunol. 16: 851-854 1986, "A Novel Approach for Preparing Anti-T-Cell Receptor Constant Region Antibodies
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?